Awarded TED · Source · Language: Español

Spain · Medical equipment, pharmaceuticals and personal care products

Official title · Español

Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.

Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria · Spain

View notices under this name

Official summary · Español

What is being procured?

Suministro de medicamentos principios activos: Interferon Beta 1-A, Cannabinol-Ronabinol y Avelumab, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.

Deadline Not announced
Estimated valueNot announced
PublishedAug 27, 2026
Open official notice ↗

Notice history

Procurement timeline

Follow the main stages and updates linked to this procurement procedure.

  1. Competition notice

    · TED 378009-2026

    Open official notice ↗
  2. Result notice Current notice

    · TED 592426-2026

    Open official notice ↗

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Source and reliability

TED · 592426-2026. Checked on Aug 28, 2026, 9:05 AM.

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Report an error by email